Johnson & JohnsonNew Brunswick, NJ, United States (NYSE: JNJ)

Tools:

What Additional Johnson & Johnson Information Is Available From Hoover's?

Today's Special Offer

Company Description

It's nearly impossible to get well without Johnson & Johnson (J&J). The diversified health care giant operates in three...

Headquarters:

1 Johnson & Johnson Plaza
New Brunswick, NJ 08933
United States  (Map)

Key Johnson & Johnson Financials

Company Type Public - NYSE: JNJ
Main Headquarters
Fiscal Year-End December
2007 Sales (mil.) $61,095.0
2006 Employees 122,200

Latest Johnson & Johnson Jobs powered by Monster.com

  • Molecular Diagnostics Territory Manager - Veridex - NJ/Philly/NY - (Job Number: 0806319)
  • Production Planner - (Job Number: 0806268)
  • Northern Virginia: Rheumatology Immunology Specialist: Centocor, Inc. - (Job Number: 0805149)

Rankings

  • #35 in FORTUNE 500
  • S&P 500
  • Dow Jones Industrials
  • Dow Jones Global Titans
  • #19 in FT Global 500

Competition

Competitive Landscape for Pharmaceutical Manufacture and Sale

The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...

Top Johnson & Johnson Competitors

Johnson & Johnson Executives sponsored by genius.com

Title Name & Bio Contact
Chairman and CEO William C. (Bill) Weldon Network | E-mail
Vice Chairman and CFO Robert J. Darretta Jr. Network | E-mail
VP Finance and CFO Dominic J. Caruso Network | E-mail
Are You Listed On Hoover's?
Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record.
Tools from our advertising partners:
 Resume Critique Start A Franchise

Current Johnson & Johnson News

Johnson & Johnson Discussion Grouppowered by Pluck

Loading content...

Latest Industry Video

  • interviewee
    ASCO 2007 Preview (5:07)
    06/01/07 8:50AM ET - Wachovia Capital Markets Senior Biotech Analyst George Farmer and Miller Tabak Pharmaceutical Analyst Les Fundleyder discuss new drugs coming out at this year's conference.